Positron emission tomography with fluordeoxyglucose (FDG-PET) in neurology. IPE-99/18 (Public report)

Agencia de Evaluacion de Tecnologias Sanitarias (AETS)
Record ID 31999008536
Authors' objectives:

The objective of this report is to assess the relative contribution of FDG-PET to clinical management of neurological patients. This report examines whether this technology is able to provide a higher diagnostic accuracy compared to other available technologies, if it influences the patient's therapeutic management, and if its use can further benefit them.

Authors' recommendations: There are many technically possible clinical applications of FDG-PET in neurology. Nevertheless, there are two specific situations in which this technique appears to be useful for clinical patient management: 1. Differentiation of radionecrosis from relapses or residual lesions in operated and radiated tumours (especially gliomas). 2. Epileptogenic focus lateralization or location in uncontrolled temporal epilepsies in an integrated and diagnostic strategy, addressed to indicate and plan surgical treatment.
Authors' methods: Review
Project Status: Completed
URL for project: http://www.isciii.es/aets
Year Published: 1999
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Spain
MeSH Terms
  • Neurology
  • Tomography, Emission-Computed
Organisation Name: Agencia de Evaluacion de Tecnologias Sanitarias
Contact Address: Instituto de Salud "Carlos III", Calle Sinesio Delgado 6, Pabellon 4, 28029 Madrid, Spain. Tel: +34 9 1 822 2005; Fax: +34 9 1 387 7841;
Contact Name: Luis M. Sánchez Gómez
Contact Email: luism.sanchez@isciii.es
Copyright: Agencia de Evaluacion de Tecnologias Sanitarias (AETS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.